Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
Phase 2
Completed
- Conditions
- Covid-19
- Interventions
- Biological: RUTI® vaccineBiological: Placebo
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- RUTI Immunotherapeutics S.L.
- Target Recruit Count
- 251
- Registration Number
- NCT04903184
- Locations
- 🇦🇷
Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina
🇦🇷Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
🇦🇷Hospital General, Mendoza, Argentina
© Copyright 2025. All Rights Reserved by MedPath